Publications by authors named "Amber Winter"

Claim this Profile
E
Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care.
Courtney Labé, Andrea Chehadeh, Amber Winter, Sara Pracht, Kathy M Stuebner

Vet Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Younger Age Is Associated with Favorable Outcomes in Adult Dogs with Hemangiosarcoma Receiving Adjuvant Doxorubicin Chemotherapy: Results from the PRO-DOX Study.
Antonella Borgatti, Brian D Husbands, Aaron L Sarver, Jeremy M Chacón, Todd E DeFor, Amber L Winter

Res Sq· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity Profile of eBAT, a Bispecific Ligand-Targeted Toxin Directed to EGFR and uPAR, in Mice and a Clinical Dog Model.
Rose H Dicovitsky, Jill T Schappa, Ashley J Schulte, Haeree P Lang, Ellen Kuerbitz, Amber L Winter

Toxins (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma.
Kelly M Makielski, Aaron L Sarver, Michael S Henson, Kathleen M Stuebner, Antonella Borgatti, Amber Winter

Mol Ther Oncolytics· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma.
Kelly M Makielski, Aaron L Sarver, Michael S Henson, Kathleen M Stuebner, Antonella Borgatti, Amber Winter

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective evaluation of thrombocytopenia and tumor stage as prognostic indicators in dogs with splenic hemangiosarcoma.
Alison R Masyr, Aaron K Rendahl, Amber L Winter, Antonella Borgatti, Jaime F Modiano

J Am Vet Med Assoc· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma.
Antonella Borgatti, Ann Fieberg, Amber L Winter, Kathleen Stuebner, Elizabeth Taras

Vet Comp Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of post-prostatectomy radiotherapy at a Regional Cancer Centre.
Luke Nicholls, Amber Winter, Ashley Harwood, Ashley Plank, Preeti Bagga

J Med Radiat Sci· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.
Antonella Borgatti, Amber L Winter, Kathleen Stuebner, Ruth Scott, Christopher P Ober

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR.
Antonella Borgatti, Joseph S Koopmeiners, Aaron L Sarver, Amber L Winter, Kathleen Stuebner

Mol Cancer Ther· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I clinical study to evaluate safety of orally administered, genetically engineered serovar for canine osteosarcoma.
Sara E Fritz, Michael S Henson, Emily Greengard, Amber L Winter, Kathleen M Stuebner

Vet Med Sci· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double blinded, placebo-controlled pilot study to examine reduction of CD34 /CD117 /CD133 lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma.
Daisuke Ito, Michael Childress, Nicola Mason, Amber Winter, Timothy O'Brien

F1000Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis